Fundraising Fox
Regeneron NASDAQ: REGN www.regeneron.com
Tarrytown, US · 4 known investors
Find your way into Regeneron NASDAQ: REGN www.regeneron.com
Sign up to see every warm intro you have to Regeneron NASDAQ: REGN www.regeneron.com
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Regeneron NASDAQ: REGN www.regeneron.com team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
Investors · 4
Related companies · 2
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Johnson & JohnsonJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Companies working in the same space as Regeneron NASDAQ: REGN www.regeneron.com.
Frequently asked questions
- What does Regeneron NASDAQ: REGN www.regeneron.com do?
- Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
- Who are Regeneron NASDAQ: REGN www.regeneron.com's investors?
- Regeneron NASDAQ: REGN www.regeneron.com's investors include Ridgeback Capital, Sanderling Ventures, venBio Partners, Wireframe Ventures.
- Where is Regeneron NASDAQ: REGN www.regeneron.com headquartered?
- Regeneron NASDAQ: REGN www.regeneron.com is headquartered in Tarrytown, US.